Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.55 USD | -2.44% |
|
+6.74% | +36.05% |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 270M | Capitalization | 1.04B |
---|---|---|---|---|---|
Net income 2024 * | -140M | Net income 2025 * | -51M | EV / Sales 2024 * | 6.19 x |
Net cash position 2024 * | 142M | Net cash position 2025 * | 115M | EV / Sales 2025 * | 3.44 x |
P/E ratio 2024 * |
-7.27
x | P/E ratio 2025 * |
-20.3
x | Employees | 244 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.91% |
Latest transcript on Tarsus Pharmaceuticals, Inc.
1 day | -2.44% | ||
1 week | +6.74% | ||
Current month | +1.36% | ||
1 month | -16.41% | ||
3 months | -22.57% | ||
6 months | +36.66% | ||
Current year | +36.05% |
![Extreme 24.42](/images/extremecours_fleche.png)
![Extreme 24.42](/images/extremecours_fleche.png)
![Extreme 18.99](/images/extremecours_fleche.png)
![Extreme 12.57](/images/extremecours_fleche.png)
![Extreme 10.8001](/images/extremecours_fleche.png)
![Extreme 10.8001](/images/extremecours_fleche.png)
![Extreme 10.8001](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 46 | 16-12-31 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 62 | 23-04-23 |
Sesha Neervannan
COO | Chief Operating Officer | 56 | 20-07-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Link
BRD | Director/Board Member | 78 | 16-12-31 |
Wendy Yarno
BRD | Director/Board Member | 68 | 20-11-18 |
Director/Board Member | 69 | 19-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +11.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 27.55 | -2.44% | 861,384 |
24-07-01 | 28.24 | +3.90% | 1,034,794 |
24-06-28 | 27.18 | +7.99% | 2,925,004 |
24-06-27 | 25.17 | -0.36% | 960,898 |
24-06-26 | 25.26 | -2.13% | 588,687 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.05% | 1.07B | |
+55.55% | 823B | |
+42.31% | 641B | |
-6.83% | 352B | |
+17.15% | 324B | |
+7.09% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- TARS Stock